In July 2008, the following drugs had modifications to the BOXED WARNING section: 

*Baraclude (entecavir) Tablets and Oral Solution *Exforge (amlodipine and valsartan) Tablets *Strattera (atomoxetine hydrochloride) Capsules *Tykerb (lapatinib) Tablets *Ziagen (abacavir sulfate) Tablets and Oral Solution 

In addition, the following products in July 2008 had changes to MEDICATION GUIDES: 

*Advair HFA (fluticasone propionate and salmeterol) Inhalation Aerosol for Oral Inhalation Only *Enbrel (etanercept) for Subcutaneous Injection *EC-Naprosyn (naproxen delayed-release tablets), Naprosyn (naproxen tablets), *Anaprox/Anaprox DS (naproxen sodium tablets), and Naprosyn (naproxen suspension) *Strattera (atomoxetine hydrochloride) Capsules *Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for Oral Inhalation Only *Vicoprofen (hydrocodone bitartrate/ibuprofen) Tablets *Ziagen (abacavir sulfate) Tablets and Oral Solution 

Source: FDA


Zynchros Pharmacy Services